Micrometastases and transplantation

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 5, 1996, Pages 519-524

  Sharp, J Graham ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; CANCER RECURRENCE; CANCER REGRESSION; DRUG MEGADOSE; HEMATOPOIESIS; IMMUNOCYTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; HUMANS; NEOPLASM, RESIDUAL; NEOPLASMS;

EID: 0029853912     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.519     Document Type: Article

References (27)

1. Bierman, P.J. Quoted by Vaugh, T.J. ASCO Meeting, Philadelphia, May 1996.
2. Vahdat, L. & Antman, K.H. Dose-intensive therapy in breast cancer. In High Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells, eds. Armitage, J.O. & Antman, K.H. Williams & Wilkins, Baltimore, 1995, p. 802.
3. Longo, D.L., Fisher, R.I. & Magrath, I.T. Lymphomas: A clinical approach to the less common entities. In ASCO Educational Book. American Society of Clinical Oncology, Alexandria, VA, 1996, p. 302.
4. Rill, D.R., Santana, V.M., Roberts, W.M., et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
5. Deisseroth, A.B., Zu, Z., Claxton, D., et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994.
6. Sharp, J.G., Joshi, S.S., Armitage, J.O., et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 79:1074, 1992.
7. Sharp, J.G., Kessinger, A., Mann, S., et al: Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J. Clin. Oncol. 14:214, 1996.
8. Miller, C.B., Horowitz, M.M., Jones, R.J., et al: Autotransplants for acute myelogenous leukemia (AML): Effect of purging with 4-hydroperoxycyclophosphamide (4HC). Am. Soc. Clin. Oncol. 15:338, 1996.
9. O'Reilly, M.S., Holmgren, L., Shirig, Y., et al: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastasis by a Lewis lung carcinoma. Cell 79:315, 1994.
10. Gribben, J.G., Blake, K.W., Coral, F., et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325:1525, 1991.
11. Sander, C.A., Yano, T., Clark, H.M., et al: p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994, 1993.
12. Dohner, H., Konstanze, F., Bentz, M., et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580, 1995.
13. Campana, D. & Pui, C. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 85:1416, 1995.
14. Osborn, M.P. & Rosen, P.P. Detection and management of bone marrow micrometastases in breast cancer. Oncology 8:25, 1994.
15. Sharp, J.G., Bishop, M., Chan, W.C., et al. Application of malignant cell detection techniques to improve the outcome of high-dose therapy and transplantation for lymphoma, leukemia and breast cancer. In Hematopoietic Stem Cells. The Method Manual, eds. Wunder, E., et al. Karger, Basel, 1996.
16. Chan, W.C., Wu, G., Greiner, T., et al: Detection of tumor contamination in peripheral blood stem cells in patients with lymphoma using cell culture and PCR technology. J. Hematother. 3:174, 1994.
17. Sharp, J.G., Bishop, M., Chan, W.C., et al. Detection of minimal residual disease (MRD) in hematopoietic tissues. In Bone Marrow Transplantation: Foundations of the 21st Century, eds. Sackstein, R., Janssen, W.E., & Elfenbein, G.J. New York Academy of Sciences, New York, 1995, p. 242.
18. Krismann, M., Todt, B., Schroder, J., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol. 13:2769, 1995.
19. Sharp, J.G., Chan, W.C., Wu, G.Q., et al. Progress in the detection of minimal lymphoma and new approaches to the treatment of minimal disease. In AMBT VII, eds. Dicke, K.A. & Keating, A. Seventh International Symposium, Arlington, TX, 1995, p. 633.
20. Gribben, J.G., Barber, M., Freedman, A.S., et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994.
21. Kessinger, A., Armitage, J., Bierman, P., et al. Clinical outcome of peripheral blood stem cell support. Med. Oncol. 11:43, 1994.
22. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
23. Shpall, E.J., & Jones, R.B. Release of tumor cells from bone marrow. Blood 83:623, 1994.
24. Talmadge, J.E., Reed, E.C., Kessinger, A., et al. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant. 17:101, 1996.
25. Reading, C.L. Does CD34+ cell selection enrich malignant stem cells in B cell (and other) malignancies. J. Hematother. 5:97, 1996.
26. Macdonald, D., Barrett, A.J., Bungey, J., et al. Acute myeloid leukemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptor. Br. J. Haematol. 77:43, 1991.
27. Sharp, J.G., Kessinger, A., Armitage, J.O., et al. Influence of minimal tumor contamination of hematopoietic harvests on clinical outcome of patients undergoing high dose therapy and transplantation. In ABMT VI, eds. Dicke, K. & Keating, A. Sixth International Symposium, Arlington, TX, 1993, p. 223.